In this issue:
- The Advangen Inc. Japan acquisition
- Interview with the Founding Director of Biotech Healthcare Partners, Dr. Takeo Matsumoto
- Global distribution strategy for Advangen
- The science behind Advangen’s products is world class
- Advangen’s clinical study was led by top dermatologist, Professor Seiji Arase
- FAQ on the Advangen Inc. Japan Acquisition
- Advancing personalised medicine - midkine accelerating drug development
- Cellmid in the news
- Third Midkine Symposium - Kyoto, Japan April 2014
To view Newsletter please download PDF below:
